• Media Centre
  • Investor relations
  • Client area
  • Client area
  • Stewardship policy
  • Annual reports service

Form of Proxy

MEDPACE HOLDINGS, INC.

Notes

No. Proposition For Against Abstain
1

DIRECTOR Brian T. Carley

2

DIRECTOR Femida H Gwadry-Sridhar

3

DIRECTOR Robert O. Kraft

4

DIRECTOR August J. Troendle

5

DIRECTOR Dani S. Zander

6

To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.

7

To approve, on an advisory basis, the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting.

8

To recommend, on an advisory basis, the frequency of future advisory votes on named executive officer compensation.

9

To approve an amendment to the Companys Certificate of Incorporation to remove supermajority voting requirements.

10

To approve an amendment to the Companys Certificate of Incorporation to remove the limitation on stockholders calling special meetings of stockholders.

11

Stockholder proposal regarding giving shareholders an ability to call for a special shareholder meeting, if properly presented at the meeting.